"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...

the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge...